Disease-Free SurvivalSurvival RatePrognosisNeoplasm StagingTreatment OutcomeRetrospective StudiesSurvival AnalysisNeoplasm Recurrence, LocalCombined Modality TherapyBreast NeoplasmsKaplan-Meier EstimateFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsTumor Markers, BiologicalChemotherapy, AdjuvantLymphatic MetastasisRadiotherapy, AdjuvantImmunohistochemistryProportional Hazards ModelsCell SurvivalRadiotherapy DosageTime FactorsFluorouracilCarcinoma, Squamous CellNeoplasm InvasivenessColorectal NeoplasmsCyclophosphamideCarcinoma, Ductal, BreastMultivariate AnalysisRecurrenceProspective StudiesCarcinomaLiver NeoplasmsPredictive Value of TestsAdenocarcinomaImmunoenzyme TechniquesReceptors, EstrogenReceptor, erbB-2Risk FactorsGene Expression Regulation, NeoplasticSurvivalNeoplasm MetastasisLung NeoplasmsCisplatinAntineoplastic AgentsGraft SurvivalNeoplasm GradingVincristineCohort StudiesDisease ProgressionBone NeoplasmsDelayed DiagnosisRemission InductionDoxorubicinNeoadjuvant TherapyAge FactorsPrenatal DiagnosisOvarian NeoplasmsEtoposideEarly DiagnosisDrug Administration ScheduleCarcinoma, Non-Small-Cell LungChemoradiotherapySensitivity and SpecificitySarcomaSalvage TherapyMethotrexateReceptors, ProgesteroneRadiotherapyLymphoma, Non-HodgkinHead and Neck NeoplasmsPrednisoneHodgkin DiseaseLymph Node ExcisionActuarial AnalysisFree RadicalsLymph NodesCarcinoma, HepatocellularPancreatic NeoplasmsBrachytherapyRisk AssessmentTomography, X-Ray ComputedCarboplatinBrain NeoplasmsNeoplasms, Germ Cell and EmbryonalNeoplasm ProteinsHematopoietic Stem Cell TransplantationOsteosarcomaStomach NeoplasmsNeoplasm, ResidualTransplantation, AutologousDiagnosisRectal NeoplasmsAntibodies, MonoclonalPaclitaxelTransplantation, HomologousAntineoplastic Agents, HormonalTamoxifenUterine Cervical NeoplasmsMediastinal Neoplasms